Kansas
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Kansas: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Kansas law mirrors federal principles in intellectual property, particularly concerning patent eligibility and the non-patentability of abstract ideas. In the wake of the Myriad decision, Kansas courts have tended to interpret genetic sequences as unpatentable subject matter akin to natural phenomena.
In Kansas, as influenced by Myriad, isolated genes are not eligible for patent protection because they are considered products of nature, thus falling outside the boundaries of patentable subject matter.
The Kansas court adopted the federal standard for patentable subject matter by ruling that abstract ideas, including methods involving natural phenomena, are not patentable.
The court emphasized that any 'natural products' discovered but not altered significantly are excluded from patentability under both state and federal law.
This case reaffirmed the notion that merely isolating a naturally occurring gene does not confer patentability absent significant transformative modification.
Kansas's approach to patent law follows the same interpretive trends set by federal courts, especially concerning the Myriad decision. Both levels of courts apply a strict standard for the patentability of naturally occurring substances, aligning state interpretations with federal regulations on the scope of patentable subject matter.
Understanding genetic patent law is increasingly relevant in Kansas bar exams, particularly as it relates to recent interpretations of patent eligibility following landmark cases such as Myriad.